OP62 Polymorphisms in AKT1 and EGFR as possible new biomarkers of clinical outcome and toxicity in non-small-cell lung cancer patients treated with gefitinib

2009 ◽  
Vol 7 (4) ◽  
pp. 9
Author(s):  
E. Giovannetti ◽  
P. Zucali ◽  
C. Tibaldi ◽  
E. Smit ◽  
A. Falcone ◽  
...  
PLoS ONE ◽  
2015 ◽  
Vol 10 (5) ◽  
pp. e0129232 ◽  
Author(s):  
Xueying Zhao ◽  
Shiming Wang ◽  
Junjie Wu ◽  
Xiaoying Li ◽  
Xun Wang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document